Sumitomo Pharma Co., Ltd. (DNPUF)

Market Cap	4.74B
Revenue (ttm)	2.88B
Net Income (ttm)	131.02M
Shares Out	n/a
EPS (ttm)	0.33
PE Ratio	36.15
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	5,030
Average Volume	728
Open	13.91
Previous Close	n/a
Day's Range	10.74 - 13.91
52-Week Range	3.44 - 13.91
Beta	0.54
RSI	84.69
Earnings Date	Oct 31, 2025

About Sumitomo Pharma

Sumitomo Pharma Co., Ltd. engages in manufacture, purchase, and sale of pharmaceutical products for medical treatment in Japan, North America, and Asia. The company offers therapeutic agents for parkinson’s disease, type 2 diabetes, advanced prostate cancer, uterine fibroids and endometriosis, overactive bladder, and pediatric congenital athymia. It also provides atypical antipsychotic, generic products, antiepileptic, atypical antipsychotic, and carbapenem antibiotic. In addition, the company offers veterinary drugs, medical devices, etc. It h...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1897
• Employees: 3,832
• Stock Exchange: OTCMKTS
• Ticker Symbol: DNPUF

Financial Performance

Financial numbers in JPY